Moneycontrol
HomeNewsBusinessCoronavirus impact | Hospitals feel the pinch of infection control measures
Trending Topics

Coronavirus impact | Hospitals feel the pinch of infection control measures

Hospitals said that the insurance companies are not covering the additional costs.

April 16, 2020 / 23:08 IST
Story continues below Advertisement

Ashwini Rajan (name changed), had admitted her 64-year-old father to the emergency ward of a large private hospital in Mumbai after he suffered a heart attack. He was kept in a coronary care unit. Her father survived, and was discharged on fifth day. But Rajan's shock, she was asked pay an additional Rs 35,000. This wasn't covered as part of her insurance.

The hospital management told her that this additional cost was due to COVID-19 testing, personal protection equipment (PPE) and other related materials.

Story continues below Advertisement

Analysts estimate that the COVID-19 related infection control measures such as testing in-patients and staff, PPE for health staff, social distancing protocols and human resources costs is resulting in bills getting inflated by 15-20 percent over and above the regular charges.

Hospitals say that the insurance companies are not covering the additional costs, forcing patients to pay out of pocket.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show